BB rats develop spontaneous autoimmune insulin-dependent diabetes mellitus that is similar to human insulin-dependent diabetes. In this study, we used an in vitro islet cell cytotoxicity assay to study the possible role of natural killer (NK) cells and their soluble effector molecules in this disorder. First, the results demonstrated that in vivo treatment of acutely diabetic BB rats with anti-asialogangliosideM1 (an NK cell antiserum) but not with anti-T-lymphocyte antibodies reduces spleen cell cytotoxic activity to islets in vitro. Flow microfluorometry (FMF)-sorting experiments were then used to confirm that the splenic cytotoxic effector cell in acutely diabetic BB rats is a CD8+/CD5− NK cell. Further analysis demonstrated that both FMF-sorted NK cell populations from Wistar-Fu rt h rats and unfractionated spleen cells from athymic nu/nu rats with high intrinsic NK cell activity also exhibit high islet cell cytotoxic activity in vitro. Finally, we found that the kinetics and differential cytotoxic activity of NK cells toward islets in vitro could be mimicked by NK cell culture supernatants containing high levels of NK cytotoxic factor (NKCF). The islet cytotoxic activity of these culture supernatants was specifically inhibited by the addition of anti-NKCF monoclonal antibody. These results demonstrate that NK cells from diabetic and nondiabetic rats are cytotoxic to islet cells in vitro. They further suggest that this cytotoxic effect may be mediated in part through the production and release of soluble factors such as NKCF.
Skip Nav Destination
Article navigation
Original Articles|
July 01 1990
Intrinsic Cytotoxicity of Natural Killer Cells to Pancreatic Islets In Vitro
Naoto Akamura;
Naoto Akamura
Departments of Medicine and Pathology, University of Massachusetts Medical Center
Worcester, Massachusetts
Department of Pathology, University of Connecticut Health Center
Farmington, Connecticut
Laboratory of Experimental Immunology, Biological Response Modifiers Program, National Cancer Institute, Frederick Cancer Research Facilityx
Frederick, Maryland
Search for other works by this author on:
Bruce A Woda;
Bruce A Woda
Departments of Medicine and Pathology, University of Massachusetts Medical Center
Worcester, Massachusetts
Department of Pathology, University of Connecticut Health Center
Farmington, Connecticut
Laboratory of Experimental Immunology, Biological Response Modifiers Program, National Cancer Institute, Frederick Cancer Research Facilityx
Frederick, Maryland
Search for other works by this author on:
Anna Tafuri;
Anna Tafuri
Departments of Medicine and Pathology, University of Massachusetts Medical Center
Worcester, Massachusetts
Department of Pathology, University of Connecticut Health Center
Farmington, Connecticut
Laboratory of Experimental Immunology, Biological Response Modifiers Program, National Cancer Institute, Frederick Cancer Research Facilityx
Frederick, Maryland
Search for other works by this author on:
Dale L Greiner;
Dale L Greiner
Departments of Medicine and Pathology, University of Massachusetts Medical Center
Worcester, Massachusetts
Department of Pathology, University of Connecticut Health Center
Farmington, Connecticut
Laboratory of Experimental Immunology, Biological Response Modifiers Program, National Cancer Institute, Frederick Cancer Research Facilityx
Frederick, Maryland
Search for other works by this author on:
Craig W Reynolds;
Craig W Reynolds
Departments of Medicine and Pathology, University of Massachusetts Medical Center
Worcester, Massachusetts
Department of Pathology, University of Connecticut Health Center
Farmington, Connecticut
Laboratory of Experimental Immunology, Biological Response Modifiers Program, National Cancer Institute, Frederick Cancer Research Facilityx
Frederick, Maryland
Search for other works by this author on:
John Ortaldo;
John Ortaldo
Departments of Medicine and Pathology, University of Massachusetts Medical Center
Worcester, Massachusetts
Department of Pathology, University of Connecticut Health Center
Farmington, Connecticut
Laboratory of Experimental Immunology, Biological Response Modifiers Program, National Cancer Institute, Frederick Cancer Research Facilityx
Frederick, Maryland
Search for other works by this author on:
William Chick;
William Chick
Departments of Medicine and Pathology, University of Massachusetts Medical Center
Worcester, Massachusetts
Department of Pathology, University of Connecticut Health Center
Farmington, Connecticut
Laboratory of Experimental Immunology, Biological Response Modifiers Program, National Cancer Institute, Frederick Cancer Research Facilityx
Frederick, Maryland
Search for other works by this author on:
Eugene S Handler;
Eugene S Handler
Departments of Medicine and Pathology, University of Massachusetts Medical Center
Worcester, Massachusetts
Department of Pathology, University of Connecticut Health Center
Farmington, Connecticut
Laboratory of Experimental Immunology, Biological Response Modifiers Program, National Cancer Institute, Frederick Cancer Research Facilityx
Frederick, Maryland
Search for other works by this author on:
John P Mordes;
John P Mordes
Departments of Medicine and Pathology, University of Massachusetts Medical Center
Worcester, Massachusetts
Department of Pathology, University of Connecticut Health Center
Farmington, Connecticut
Laboratory of Experimental Immunology, Biological Response Modifiers Program, National Cancer Institute, Frederick Cancer Research Facilityx
Frederick, Maryland
Search for other works by this author on:
Aldo A Rossini
Aldo A Rossini
Departments of Medicine and Pathology, University of Massachusetts Medical Center
Worcester, Massachusetts
Department of Pathology, University of Connecticut Health Center
Farmington, Connecticut
Laboratory of Experimental Immunology, Biological Response Modifiers Program, National Cancer Institute, Frederick Cancer Research Facilityx
Frederick, Maryland
Search for other works by this author on:
Address correspondence and reprint requests to Aldo A. Rossini, MD, Diabetes Division, University of Massachusetts Medical Center, 55 Lake Avenue North, Worcester, MA 01655.
Diabetes 1990;39(7):836–843
Article history
Received:
August 21 1989
Revision Received:
March 13 1990
Accepted:
March 13 1990
PubMed:
2191887
Citation
Naoto Akamura, Bruce A Woda, Anna Tafuri, Dale L Greiner, Craig W Reynolds, John Ortaldo, William Chick, Eugene S Handler, John P Mordes, Aldo A Rossini; Intrinsic Cytotoxicity of Natural Killer Cells to Pancreatic Islets In Vitro. Diabetes 1 July 1990; 39 (7): 836–843. https://doi.org/10.2337/diab.39.7.836
Download citation file:
49
Views